Diabetic foot infection: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
== |
== Background == |
||
===Microbiology=== |
|||
⚫ | |||
⚫ | |||
*Typically polymicrobial, including: |
|||
⚫ | |||
**[[Staphylococcus species]] |
|||
**[[Streptococcus species]] |
|||
⚫ | |||
**[[Anaerobes]] |
|||
⚫ | |||
== Management == |
|||
⚫ | |||
* Osteomyelitis |
|||
** Traditionally, 6 weeks of parenteral therapy |
|||
** May be able to shorten to 3 weeks based on more recent evidence[[CiteRef::gariani2020th]] |
|||
⚫ | |||
⚫ | |||
[[Category:Skin and soft tissue infections]] |
[[Category:Skin and soft tissue infections]] |
Revision as of 19:22, 13 January 2021
Background
Microbiology
- Typically polymicrobial, including:
- Staphylococcus species
- Streptococcus species
- Proteobacteria (Gram-negative bacterial genus that includes enterics)
- Anaerobes
- Anaerobes are more likely to be involved in deeper, more chronic ulcers
Management
- Osteomyelitis
- Traditionally, 6 weeks of parenteral therapy
- May be able to shorten to 3 weeks based on more recent evidence1
Further Reading
- The Neuropathic Diabetic Foot Ulcer Microbiome IsAssociated With Clinical Factors. Diabetes. 2013;62:923-930.
References
- ^ Karim Gariani, Truong-Thanh Pham, Benjamin Kressmann, François R Jornayvaz, Giacomo Gastaldi, Dimitrios Stafylakis, Jacques Philippe, Benjamin A Lipsky, İlker Uçkay. Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial. Clinical Infectious Diseases. 2020. doi:10.1093/cid/ciaa1758.